U.S. flag

An official website of the United States government

NM_000098.3(CPT2):c.1646G>A (p.Gly549Asp) AND Carnitine palmitoyltransferase II deficiency

Germline classification:
Uncertain significance (3 submissions)
Last evaluated:
Jan 11, 2024
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000202475.19

Allele description [Variation Report for NM_000098.3(CPT2):c.1646G>A (p.Gly549Asp)]

NM_000098.3(CPT2):c.1646G>A (p.Gly549Asp)

Gene:
CPT2:carnitine palmitoyltransferase 2 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
1p32.3
Genomic location:
Preferred name:
NM_000098.3(CPT2):c.1646G>A (p.Gly549Asp)
HGVS:
  • NC_000001.11:g.53213264G>A
  • NG_008035.1:g.21836G>A
  • NM_000098.3:c.1646G>AMANE SELECT
  • NM_001330589.2:c.1577G>A
  • NP_000089.1:p.Gly549Asp
  • NP_000089.1:p.Gly549Asp
  • NP_001317518.1:p.Gly526Asp
  • NC_000001.10:g.53678936G>A
  • NM_000098.2:c.1646G>A
  • P23786:p.Gly549Asp
  • c.1646G>A (p.Gly549Asp)
Protein change:
G526D
Links:
UniProtKB: P23786#VAR_007971; dbSNP: rs186044004
NCBI 1000 Genomes Browser:
rs186044004
Molecular consequence:
  • NM_000098.3:c.1646G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001330589.2:c.1577G>A - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Carnitine palmitoyltransferase II deficiency (CPT2)
Synonyms:
Carnitine palmitoyl transferase 2 deficiency; Carnitine palmitoyltransferase deficiency type 2
Identifiers:
MONDO: MONDO:0015515; MedGen: C0342790

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000153670GeneReviews
no classification provided
not providedgermlineliterature only

PubMed (1)
[See all records that cite this PMID]

SCV001386080Labcorp Genetics (formerly Invitae), Labcorp
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Uncertain significance
(Jan 11, 2024)
germlineclinical testing

PubMed (3)
[See all records that cite these PMIDs]

SCV002092670Natera, Inc.
no assertion criteria provided
Uncertain significance
(Oct 6, 2021)
germlineclinical testing

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing, literature only

Citations

PubMed

Carnitine Palmitoyltransferase II Deficiency..

Wieser T.

2004 Aug 27 [updated 2019 Jan 3]. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews(®) [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2024.

PubMed [citation]
PMID:
20301431

Novel mutations associated with carnitine palmitoyltransferase II deficiency.

Taggart RT, Smail D, Apolito C, Vladutiu GD.

Hum Mutat. 1999;13(3):210-20.

PubMed [citation]
PMID:
10090476
See all PubMed Citations (4)

Details of each submission

From GeneReviews, SCV000153670.3

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedliterature only PubMed (1)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

From Labcorp Genetics (formerly Invitae), Labcorp, SCV001386080.5

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (3)

Description

This sequence change replaces glycine, which is neutral and non-polar, with aspartic acid, which is acidic and polar, at codon 549 of the CPT2 protein (p.Gly549Asp). This variant is present in population databases (rs186044004, gnomAD 0.006%). This missense change has been observed in individual(s) with carnitine palmitoyltransferase II deficiency (PMID: 10090476, 16996287). ClinVar contains an entry for this variant (Variation ID: 130890). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

From Natera, Inc., SCV002092670.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Nov 24, 2024